*ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, BDD), FC-VWF-XTEN FUSION PROTEIN — all Canadian products
6 DINs
6 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is *ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, BDD), FC-VWF-XTEN FUSION PROTEIN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02447967 | ALTUVIIIO | SANOFI-AVENTIS CANADA INC | Powder For Solution | Intravenous | *ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, BDD), FC-VWF-XTEN FUSION PROTEIN 3000 UNIT | Marketed | |
| 02448114 | ALTUVIIIO | SANOFI-AVENTIS CANADA INC | Powder For Solution | Intravenous | *ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, BDD), FC-VWF-XTEN FUSION PROTEIN 250 UNIT | Approved | |
| 02448122 | ALTUVIIIO | SANOFI-AVENTIS CANADA INC | Powder For Solution | Intravenous | *ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, BDD), FC-VWF-XTEN FUSION PROTEIN 500 UNIT | Marketed | |
| 02448130 | ALTUVIIIO | SANOFI-AVENTIS CANADA INC | Powder For Solution | Intravenous | *ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, BDD), FC-VWF-XTEN FUSION PROTEIN 1000 UNIT | Marketed | |
| 02448149 | ALTUVIIIO | SANOFI-AVENTIS CANADA INC | Powder For Solution | Intravenous | *ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, BDD), FC-VWF-XTEN FUSION PROTEIN 2000 UNIT | Marketed | |
| 02448157 | ALTUVIIIO | SANOFI-AVENTIS CANADA INC | Powder For Solution | Intravenous | *ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, BDD), FC-VWF-XTEN FUSION PROTEIN 4000 UNIT | Marketed |
Browse other molecules: